TotalMarketCap

Septerna

SEPNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.218 B

$47.51 -0.77%

Close of 6 Nov 2026

As of 6 Nov 2026, Septerna (SEPN) has a market capitalization of $2.22B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$46.0M

#2740 by revenue

Earnings

-$48.9M

Loss-making

Shares outstanding

46,676,947

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #85PharvarisPHVS$2.28B
  2. #86NewAmsterdam PharmaNAMS$2.27B
  3. #87SepternaSEPN$2.22B
  4. #88Lakefront BiotherapeuticsLKFT$2.22B
  5. #89PERRIGOPRGO$2.18B

What if Septerna were worth as much as…

Open the what-if tool →

Gold $28.2T

$604,942.60

Per share 12,733× higher

Bitcoin $1.53T

$32,732.39

Per share 689× higher

Apple $5.02T

$107,457.38

Per share 2,262× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Septerna are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.